Literature DB >> 30499651

Reduced Extracellular Matrix Stiffness Prompts SH-SY5Y Cell Softening and Actin Turnover To Selectively Increase Aβ(1-42) Endocytosis.

Terra M Kruger1, Kendra J Bell1, Thiranjeewa I Lansakara2, Alexei V Tivanski2, Jonathan A Doorn1, Lewis L Stevens1.   

Abstract

Alzheimer's disease (AD), the most common neurodegenerative disorder, is characterized by the extracellular deposition of dense amyloid beta plaques. Emerging evidence suggests that the production of these plaques is initiated by the intracellular uptake and lysosomal preconcentration of the amyloid-beta (Aβ) peptide. All previous endocytosis studies assess Aβ uptake with cells plated on traditional tissue culture plastic; however, brain tissue is distinctly soft with a low-kPa stiffness. Use of an ultrastiff plastic/glass substrate prompts a mechanosensitive response (increased cell spreading, cell stiffness, and membrane tension) that potentially distorts a cell's endocytic behavior from that observed in vivo or in a more physiologically relevant mechanical environment. Our studies demonstrate substrate stiffness significantly modifies the behavior of undifferentiated SH-SY5Y neuroblastoma, where cells plated on soft (∼1 kPa) substrates display a rounded morphology, decreased actin polymerization, reduced adhesion (decreased β1 integrin expression), and reduced cell stiffness compared to cells plated on tissue culture plastic. Moreover, these neuroblastoma on softer substrates display a preferential increase in the uptake of the Aβ(1-42) compared to Aβ(1-40), while both isoforms display a clear stiffness-dependent increase of uptake relative to cells plated on plastic. Considering the brain is a soft tissue that continues to soften with age, this mechanosensitive endocytosis of Aβ has significant implications for understanding age-related neurodegeneration and the mechanism behind Aβ uptake and fibril production. Overall, identifying these physical factors that contribute to the pathology of AD may offer novel avenues of therapeutic intervention.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid; cell stiffness; endocytosis; extracellular matrix; mechanosensitive

Mesh:

Substances:

Year:  2018        PMID: 30499651     DOI: 10.1021/acschemneuro.8b00366

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  6 in total

Review 1.  Stiffness Sensing by Cells.

Authors:  Paul A Janmey; Daniel A Fletcher; Cynthia A Reinhart-King
Journal:  Physiol Rev       Date:  2019-11-21       Impact factor: 37.312

2.  A Soft Mechanical Phenotype of SH-SY5Y Neuroblastoma and Primary Human Neurons Is Resilient to Oligomeric Aβ(1-42) Injury.

Authors:  Terra M Kruger; Kendra J Bell; Thiranjeewa I Lansakara; Alexei V Tivanski; Jonathan A Doorn; Lewis L Stevens
Journal:  ACS Chem Neurosci       Date:  2020-02-28       Impact factor: 4.418

3.  Combating amyloid-induced cellular toxicity and stiffness by designer peptidomimetics.

Authors:  Mouli Konar; Debasis Ghosh; Sourav Samanta; Thimmaiah Govindaraju
Journal:  RSC Chem Biol       Date:  2021-12-23

4.  Mechanical cues protect against silica nanoparticle exposure in SH-SY5Y neuroblastoma.

Authors:  Kendra J Bell; Thiranjeewa I Lansakara; Rachel Crawford; T Blake Monroe; Alexei V Tivanski; Aliasger K Salem; Lewis L Stevens
Journal:  Toxicol In Vitro       Date:  2020-10-17       Impact factor: 3.500

5.  Investigation on the Composition of Agarose-Collagen I Blended Hydrogels as Matrices for the Growth of Spheroids from Breast Cancer Cell Lines.

Authors:  Alessandra Quarta; Nunzia Gallo; Daniele Vergara; Luca Salvatore; Concetta Nobile; Andrea Ragusa; Antonio Gaballo
Journal:  Pharmaceutics       Date:  2021-06-26       Impact factor: 6.321

6.  Fascin limits Myosin activity within Drosophila border cells to control substrate stiffness and promote migration.

Authors:  Maureen C Lamb; Chathuri P Kaluarachchi; Thiranjeewa I Lansakara; Samuel Q Mellentine; Yiling Lan; Alexei V Tivanski; Tina L Tootle
Journal:  Elife       Date:  2021-10-26       Impact factor: 8.713

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.